Clincosm LogoSign in Get a demo

Medically Assisted Procreation and Choice of the Embryo: How Far Would French People Like to go

Sponsor
University Hospital, Montpellier (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT04763551
Collaborator
(none)
300
Enrollment
1
Location
11
Anticipated Duration (Months)
27.3
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

In today's context of bioethics laws revision concerning Medically Assisted Procreation, the investigators focus on the opinion of couples resorting to In Vitro Fertilization on a fundamental, much debated issue ; the choice of the embryo.

French lawmakers fear the investigators might be drifting towards embryo selection procedures, but no study allows us to state this is what patients request. This study aims at determining, among the population of patients who resort to Medically Assisted Procreation in France, the ratio of patients who are willing to select the embryo due to its genetic characteristics.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    300 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    Medically Assisted Procreation and Choice of the Embryo: How Far Would French People Like to go - An Opinion Survey Among Patients Resorting to in Vitro Fertilization (IVF) in France.
    Actual Study Start Date :
    Feb 1, 2021
    Anticipated Primary Completion Date :
    Dec 1, 2021
    Anticipated Study Completion Date :
    Jan 1, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Rate of Medically Assisted Procreation [1 day]

      Determine, among the population of patients who resort to Medically Assisted Procreation in France, the ratio of patients who are willing to select the embryo due to its genetic characteristics

    Secondary Outcome Measures

    1. Determine the type of embryo genetic selection [1 day]

      Determine the type of embryo genetic selection those patients request

    2. Determine, among the population of patients who resort to Medically Assisted Procreation in France [1 day]

      Determine, among the population of patients who resort to Medically Assisted Procreation in France, the ratio of patients who are willing to select the embryo due to its genetic characteristics, according to the type of MAP (classical MAP, with or without gamete donation, MAP with PGD)

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion criteria:
    • Male and female IVF patients in the MAP
    Exclusion criteria:
    • Patient not fluent in French

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Uhmontpellier Montpellier France 34295

    Sponsors and Collaborators

    • University Hospital, Montpellier

    Investigators

    • Principal Investigator: Noémie Ranisavljevic, M.D., Ph.D, University Hospital, Montpellier

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University Hospital, Montpellier
    ClinicalTrials.gov Identifier:
    NCT04763551
    Other Study ID Numbers:
    • RECHMPL21_0088
    First Posted:
    Feb 21, 2021
    Last Update Posted:
    Feb 21, 2021
    Last Verified:
    Feb 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Undecided
    Plan to Share IPD:
    Undecided
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University Hospital, Montpellier
    Couple infertility with IVF indication
    Genetic indication for PGD in France
    Additional relevant MeSH terms:
    Infertility

    Study Results

    No Results Posted as of Feb 21, 2021